- Supported exchanges /
- ST /
- DVYSR.ST
Devyser Diagnostics AB (DVYSR ST) stock market data APIs
Devyser Diagnostics AB (publ) develops, manufactures, and sells diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia. The company offers products in the areas of post-transplantation; thalassemia; breast, colorectal, and ovarian cancer; non-invasive fetal RHD screening prenatal testing, hereditary, cystic fibrosis, cardiovascular, male infertility, and rapid aneuploidy analysis, as well as accessories. Its products are used for targeted cancer treatment to diagnosis genetic diseases and transplant patient follow-up. The company also provides software programs for data processing and analysis, as well as interpretation of test results; and Amplicon Suite and Advyser software programs to screen markers and follow up samples for the same patient. Devyser Diagnostics AB (publ) was incorporated in 2004 and is headquartered in Hägersten, Sweden.
Devyser Diagnostics AB Financial Data Overview
| 131.24 | |
| 134.03 | |
| - | |
| 135.02 | |
| 126.85 | |
| 71-141 | |
| 2 130 M | |
| 16 510 K | |
| 198 M | |
| -1.41 | |
| 0.738 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Devyser Diagnostics AB Fundamental Data is available in our Financial Data APIs
- Net Revenue 198 M
- EBITDA -59 900 000
- Earnings Per Share -4.37
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Devyser Diagnostics AB Earnings via APIs
- Latest Release 2024-10-30
- EPS/Forecast -1.07
Get Devyser Diagnostics AB End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
